Increasing Patient Activation to Improve Health and Reduce Costs

Slides:



Advertisements
Similar presentations
TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
Advertisements

LEUCEMIA MIELOIDE AGUDA TIPO 0
National Prevention Strategy
The Health Services Researcher of 2020: A Summit on the Future of HSR Data and Methods Learning 2.0: Robust, Rigorous, Relevant, and Rapid Paul Wallace.
SMART GOALS The First Step Toward Improvement
Building a New Payment System: Stakeholder Perspectives on Principles and Elements Robert L. Broadway, FHFMA VP of Corporate Strategy, Bethesda Healthcare.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 38.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
An overview of the National Performance Measures 118 NOVEMBER 2011 THE CORPORATION FOR NATIONAL & COMMUNITY SERVICE.
Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.
Patient Activation & Engagement Basics
THE COMMONWEALTH FUND 1 Comparing Health Care Systems Performance: Opportunities for Learning from Abroad Alliance for Health Reform April 11, 2008 Robin.
Engaging Consumers to Improve Health and Reduce Costs
1 Physicians Involved in the Care of Patients with Recently Diagnosed Cancer CanCORS Provider Composition Writing Group Academy Health Annual Research.
1 The SEP Gradient, Race, or the SEP Gradient and Race: Understanding Disparities in Child Health and Functioning Lisa Dubay, PhD, ScM The Urban Institute.
1 TennCare Diabetes Program Evaluation Presentation to AcademyHealth Kenton Johnston, MPH, MS, MA June 4, 2007 An Individually-Matched Control Group Evaluation.
The Impact of Drug Benefit Caps Geoffrey Joyce, PhD.
WE BUILD A BRIGHTER FUTURE together American Hospitals Association Annual Meeting April 29, 2013 Raymond J. Baxter, PhD Senior Vice President, Community.
Business Transaction Management Software for Application Coordination 1 Business Processes and Coordination.
Chronic disease self management – a systematic review of proactive telephone applications Carly Muller Dean Schillinger Division of General Internal Medicine.
Partnership for Quality Education (PQE) Partnership for Quality Education (PQE) Collaborative Interprofessional Team Education Initiative (CITE) Carol.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Title Subtitle.
0 - 0.
ALGEBRAIC EXPRESSIONS
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
MULTIPLYING MONOMIALS TIMES POLYNOMIALS (DISTRIBUTIVE PROPERTY)
ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.
MULTIPLICATION EQUATIONS 1. SOLVE FOR X 3. WHAT EVER YOU DO TO ONE SIDE YOU HAVE TO DO TO THE OTHER 2. DIVIDE BY THE NUMBER IN FRONT OF THE VARIABLE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
ZMQS ZMQS
STATISTICAL INFERENCE ABOUT MEANS AND PROPORTIONS WITH TWO POPULATIONS
Micro Focus Research 1 As far as youre aware, how does your organization plan to drive business growth over the next three years? (Respondents' first choices)
Young and Uninsured: Insurance Patterns of Adolescent and Young Adult (AYA) Cancer Survivors 2014 Applied Demography Conference Susanne Schmidt, Helen.
Survey of People with Disabilities in the Framework of the Evaluation of the Laron Law Research conducted by Mayers-Jdc-Brookdale Institute and.
Providing Effective Feedback
1 Performance Management Challenges and Opportunities Harry P. Hatry The Urban Institute Washington DC.
ABC Technology Project
©2012 MFMER | slide-1 Family History Information Helps Inform Chronic Pain Treatment Elizabeth Pestka, MS, PMHCNS-BC, APNG Cynthia Townsend, PhD, LP Emily.
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
© S Haughton more than 3?
1 Department of Medical Assistance Services DD Waiver Provider Training Department of Medical Assistance Services Division.
Twenty Questions Subject: Twenty Questions
Promoting Rational Drug Use in the Community Monitoring and evaluation.
Linking Verb? Action Verb or. Question 1 Define the term: action verb.
Squares and Square Root WALK. Solve each problem REVIEW:
Lecture 3 Validity of screening and diagnostic tests
Lets play bingo!!. Calculate: MEAN Calculate: MEDIAN
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
Chapter 5 Test Review Sections 5-1 through 5-4.
GG Consulting, LLC I-SUITE. Source: TEA SHARS Frequently asked questions 2.
7/16/08 1 New Mexico’s Indicator-based Information System for Public Health Data (NM-IBIS) Community Health Assessment Training July 16, 2008.
Addition 1’s to 20.
25 seconds left…...
Test B, 100 Subtraction Facts
Week 1.
1. 2 Easy-to-Use Administrator Features 3 Customisable Screen Cutoff Scores.
We will resume in: 25 Minutes.
1 Unit 1 Kinematics Chapter 1 Day
© 2006 Prentice Hall Leadership in Organizations 11-1 Chapter 11 Leadership in Teams and Decision Groups.
1 Chapter 20: Statistical Tests for Ordinal Data.
Patient Activation and Motivational Interviewing Presented by: Susan Butterworth, PhD, MS Associate Professor Oregon Health & Science University President,
Measuring knowledge, skills and confidence to self manage. Patient Activation Dr Alf Collins Clinical Associate in Person Centred Care The Health Foundation.
Consumer Directed Health Plans and Patient Activation Judith Hibbard Jessica Greene Martin Tusler University of Oregon Funding Provided by the Robert Wood.
Addressing Chronic Physical and Mental Health Needs in Affordable Housing.
Southern Illinois University Edwardsville,
Presentation transcript:

Increasing Patient Activation to Improve Health and Reduce Costs Judith H. Hibbard, DrPH Institute for Policy Research and Innovation University of Oregon

The Need to Do Better with Less Patients are an important resource in health care. We won’t reach quality goals and improved outcomes without patient engagement

There is great variation in patient activation in any population group Measurement would allow us to: To know who needs more support To target the types of support and information patients and consumers need To evaluate efforts to increase activation To Evaluate quality Jessie and I both were interested in --all that we are asking of consumers and patients in our current health care environment. Although we started with the same question we took different paths to get there. I will share with you – my path -- and what we learned in the process I started with the idea– if this is important– -- this idea of engagement or activaiton– then we should be measuring it. Like everything else in healthcare we measure what matters– and in doing so we shine the light on problems and illuminate solutions. Starting with the idea that people should be more involved– we do know there are differences – shouldn’t we know about those differences before we ask people….. So if we could measure- Non swimmers– deep end of the pool Many reasons to be able to measure– share with you what we learned when we did.

Measurement of Patient Activation Share key insights Implications Applications to improve care and outcomes

What Does it Mean to Be Activated ? It is about helping people understand their own role in the care process It is when people have the skill and feel capable of taking on the job of self-management

Patient Activation Measurement (PAM) Difficulty Structure of 13 Items Measurement Properties Uni-dimensional Interval Level Guttman-Like Scale Unidimensional Interval Level Guttman-like 13 items– used RASCH to create a measure that much stronger than most social science measures

PAM 13 Question * Related instruments: PAM 10, PAM 2, Clinician PAM 7

Activation is developmental In depth interview Percent of people at the low end… Source: J.Hibbard, University of Oregon

Emotion plays a profound role in patient activation

Activation Level is Predictive of Behaviors Research consistently finds that those who are more activated are: Engaged in more preventive behaviors Engaged in more healthy behaviors Engaged in more disease specific self-management behaviors Engaged in more health information seeking behaviors

Level of activation is linked with each behavior Source: US National sample 2004

Behaviors in Medical Encounter by Activation Level

Insights Use activation level to determine what are realistic “next steps” for individuals to take Many of the behaviors we are asking of people are only done by those in highest level of activation When we focus on the more complex and difficult behaviors– we discourage the least activated Start with behaviors more feasible for patients to take on, increases individual’s opportunity to experience success What about people who are not activated, are we just discouraging them further? start with behaviors that are feasible– whether the clinical encounter– telephonic coaching– employer communications– -- the idea is to help or People gain a sense of competency: Experiencing success Physician support is important Encouragement Seeing others like them succeed.

When activation changes several behaviors change 11 of 18 behaviors show significant improvement within the Increased Growth Class compared to the Stable Growth Class

Activation can predict utilization and health outcomes two years into the future for diabetics % change for a 1 point change in PAM Score 10 Point Gain in PAM Score 54 (L2) vs. 64(L3) P Hospitalization 1.7% decline 17% decreased likelihood of hospitalization .03 Good A1c control (HgA1c < 8%) 1.8% gain 18% greater likelihood of good glycemic control .01 A1c testing 3.4% gain 34% greater likelihood of testing LDL-c testing Carol Remmers. The Relationship Between the Patient Activation Measure, Future Health Outcomes, and Health Care Utilization Among Patients with Diabetes. Kaiser Care Management Institute, PhD Dissertation. Multivariate analysis which controlled for age group, gender, race, comorbidities and number of diabetes-related prescriptions.

Low activation signals problems (and opportunities) 71% high, 29% low CTM Low score = 23% readmitted Overall in the study – 14% readmit, 15% returned Study population – Age 50 to , At least one serious chronic condition 16

Using the PAM to Improve Care Evaluations Improve efficiencies Improve efficacy Population based approaches Individual tailored approaches Who are you are touching

Tailoring Support to Activation Levels Discusses the development objectives for each level of activation This is a progressive model, not a bucket model. We want to move folks from one level to the next, leaving behind the characteristics of the previous level Even at level 4 there is work to do! Our portfolio products (training, CFA, Virtual Coach) address these levels of activation – we start where the individual is and help them realize success through small steps

Tailored Coaching Study Intervention group coached based on level of activation. Control group was “usual care” coaching (DM company) Examined changes in claims data, clinical indicators, and activation levels 6 month Intervention period.

Coaches allocated more talk time to lower activation participants when they had access to PAM scores Intervention and control coaches both spend an average of 16 minutes per call. Intervention (coaches know pam level) coaches spend an average of 18 minutes per call with activation level 1 patients. They spend an average of 16 minutes per call with level 4 patients. Control group (coaches do NOT know patient pam level) spend an average of 16 minutes with both level 1 and level 4 patients (this difference between intervention and control -- broken down by pam level, is statistically significant at .05)

PAM tailored coaching resulted in a statistically significant greater gains in activation Intervention group went from 64.3 to 68.9 (six months or less-- this is from their first pam to their 3rd pam) control went from 65.6 to 67 (also 1st to 3rd pam). most of the gains in the intervention group were in levels one and two. The intervention group was coached using a tailored to pam level approach. the control group got "usual coaching”in the intervention group (where coaches knew activation score) talk times are significantly shorter among those who are more activated. In the control group (where coaches did not know activation score) talk times are significantly LONGER for patients who are MORE activated. N.=245 in intervention group; N=112 in control group. Only those with 3 PAM scores are included. Repeated measures shows that the gains in activation are significant in the intervention group and not significant for the control group (P<.001)

Adherence to Recommended Treatments PAM-tailored Intervention vs. Usual Coaching Control

Tailored coaching can improve adherence and reduce unwarranted utilization Clinical Indicators* Medications: intervention group increased adherence to recommended immunizations and drug regimens to a greater degree than the control group. This included getting influenza vaccine. Blood Pressure: Intervention group had a significantly greater drop in diastolic as compared to control group. LDL: Intervention group had a significantly greater reduction in LDL, as compared to the control group. A1c: Both intervention and control showed improvements in A1c. Hibbard, J, Green, J, Tusler, M. Improving the Outcomes of Disease Management by Tailoring Care to the Patient’s Level of Activation. The American Journal of Managed Care, V.15, 6. June 2009 *Using repeated measures, and controlling for baseline measures 23 23

Tailoring had a positive impact on all patient outcomes Findings consistent across all outcome measures Results are compared to usual coaching Valuable Implementation lessons learned along the way

Greater Activation is Related to Better Outcomes (in multivariate analysis) Prevention Colon Mammograms Pap Smears .00 .02*** .01** Clinical Indicators in Normal Range Healthy Behaviors Not Obese Not Smoking Costly Utilization Lower Hospital Lower ER .04*** .00*** .01*** Systolic Diastolic HDL Triglycerides A1C .01* Controlling for age, income, gender, and number of chronic diseases

Providers are increasing paid on outcomes Total costs Clinical outcomes Patient Experience Panel size Will they tap into the resource that patients represent?

Applications Brief interventions in the clinical setting– with follow-up. Medical home Team approach– and differential allocation of resources Care transitions and reducing hospital re-admissions Wellness, disease management

Being Patient Centered: Means meeting people where they are Providing behavioral support that meets the individual’s needs Measurement is key to making progress in this area